In vivo characterization of weev
Ended Definitive Contract Awarded Last action
- Contract number
- W911QY15C0103
- Awardee
-
Texas Biomedical Research Institute UEI J4EYPCJDQ1H6
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $2,305,534
Award facts
- Contract value 100% obligated
- $2,305,533.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Antonio, TX 78227, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,655,486 | |
| Other Administrative Action | $0 | |
| Original award | $650,048 |
About this award
This federal contract award, W911QY15C0103, was issued by the Joint PEO Chemical and Biological Defense to the Texas Biomedical Research Institute, doing business as the Southwest Foundation For Biomedical Research. The $2,305,533.82 contract is a Firm Fixed Price Definitive Contract with no set-aside designation. The contract has an ultimate completion date of March 27, 2017.
The Texas Biomedical Research Institute is a leading independent biomedical research organization that specializes in infectious disease research, particularly focused on HIV/AIDS, tuberculosis, malaria, and emerging pathogens. The institute operates the Southwest National Primate Research Center and has expertise in animal models, preclinical studies, and vaccine development. This contract award supports the institute's work in providing critical research services and resources to the government in the area of biomedical science.
In addition to this specific contract award, the Texas Biomedical Research Institute holds two significant federal contract Indefinite Delivery Vehicles (IDVs) - one from the National Institute of Allergy and Infectious Diseases (NIAID) valued at up to $146.3 million for pre-clinical models of infectious diseases, and another from the Office of the Assistant Secretary for Preparedness and Response valued at up to $100 million for biological animal model and medical countermeasure development support. These IDVs demonstrate the institute's pivotal role in supporting federal efforts to enhance pandemic preparedness and response capabilities through its biomedical research expertise.
Quick answers
Who was awarded contract W911QY15C0103?
W911QY15C0103 was awarded to Texas Biomedical Research Institute by ACC Aberdeen Proving Ground (Army Contracting Command) on September 4, 2015.
How much is contract W911QY15C0103 worth?
The government has obligated $2,305,534 on W911QY15C0103.
Which agency awarded contract W911QY15C0103?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY15C0103, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911QY15C0103 competed?
The extent of competition for W911QY15C0103 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award